← Open Payments lookup

ELIZABETH GABELMAN: Open Payments

NPI 1598528077 · GLEN BURNIE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,874 in 90 payments from 22 companies in 2025. Trend: 2023 $0 · 2024 $1,179 · 2025 $1,874

Food & beverage: $1,874
CompanyPaymentsAmount
Novo Nordisk Inc25$588
Lilly USA, LLC11$232
ABBVIE INC.11$171
AstraZeneca Pharmaceuticals LP5$105
Dexcom, Inc.5$94
PFIZER INC.5$90
Merck Sharp & Dohme LLC3$70
Boehringer Ingelheim Pharmaceuticals, Inc.3$68
Bayer Healthcare Pharmaceuticals Inc.3$60
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$60

Products named: Rybelsus, MOUNJARO, Ozempic, Wegovy, VRAYLAR, Dexcom G6 Transmitter, GARDASIL 9, JARDIANCE.

Industry payments across MD — which companies pay providers there.